Smith & Nephew plc (SNN)
NYSE: SNN · Real-Time Price · USD
25.21
-0.30 (-1.18%)
Nov 20, 2024, 4:00 PM EST - Market closed
Smith & Nephew Revenue
Smith & Nephew had revenue of $2.83B in the half year ending June 29, 2024, with 8.73% growth. This brings the company's revenue in the last twelve months to $5.64B, up 5.48% year-over-year. In the year 2023, Smith & Nephew had annual revenue of $5.55B with 6.40% growth.
Revenue (ttm)
$5.64B
Revenue Growth
+5.48%
P/S Ratio
n/a
Revenue / Employee
$295,687
Employees
19,081
Market Cap
10.74B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5.55B | 334.00M | 6.40% |
Dec 31, 2022 | 5.22B | 3.00M | 0.06% |
Dec 31, 2021 | 5.21B | 652.00M | 14.30% |
Dec 31, 2020 | 4.56B | -578.00M | -11.25% |
Dec 31, 2019 | 5.14B | 234.00M | 4.77% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Solventum | 8.22B |
Encompass Health | 5.22B |
Catalent | 4.42B |
Dr. Reddy's Laboratories | 3.58B |
AptarGroup | 3.57B |
BioMarin Pharmaceutical | 2.75B |
Globus Medical | 2.48B |
Sarepta Therapeutics | 1.64B |
SNN News
- 7 days ago - Big investors call for break-up of Smith & Nephew, FT reports - Reuters
- 10 days ago - Smith & Nephew: Ready To Reap Demographic, Turnaround Dividends - Seeking Alpha
- 19 days ago - Smith & Nephew plc (SNN) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha
- 21 days ago - Smith & Nephew slashes annual revenue forecast on weak China - Reuters
- 5 weeks ago - RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design - GlobeNewsWire
- 6 weeks ago - Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery - GlobeNewsWire
- 2 months ago - First cases using Smith+Nephew's new CATALYSTEM™ Primary Hip System completed; surgeons hail precision, efficiency and reproducibility - GlobeNewsWire
- 2 months ago - Smith+Nephew brings pre-operative planning and accuracy to total ankle replacement with new TOTAL ANKLE Patient-Matched Guides - GlobeNewsWire